Neurobiology of the major psychoses: a translational perspective on brain structure and function-the FOR2107 consortium.


Journal

European archives of psychiatry and clinical neuroscience
ISSN: 1433-8491
Titre abrégé: Eur Arch Psychiatry Clin Neurosci
Pays: Germany
ID NLM: 9103030

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 27 06 2018
accepted: 19 09 2018
pubmed: 30 9 2018
medline: 22 4 2020
entrez: 30 9 2018
Statut: ppublish

Résumé

Genetic (G) and environmental (E) factors are involved in the etiology and course of the major psychoses (MP), i.e. major depressive disorder (MDD), bipolar disorder (BD), schizoaffective disorder (SZA) and schizophrenia (SZ). The neurobiological correlates by which these predispositions exert their influence on brain structure, function and course of illness are poorly understood. In the FOR2107 consortium, animal models and humans are investigated. A human cohort of MP patients, healthy subjects at genetic and/or environmental risk, and control subjects (N = 2500) has been established. Participants are followed up after 2 years and twice underwent extensive deep phenotyping (MR imaging, clinical course, neuropsychology, personality, risk/protective factors, biomaterials: blood, stool, urine, hair, saliva). Methods for data reduction, quality assurance for longitudinal MRI data, and (deep) machine learning techniques are employed. In the parallelised animal cluster, genetic risk was introduced by a rodent model (Cacna1c deficiency) and its interactions with environmental risk and protective factors are studied. The animals are deeply phenotyped regarding cognition, emotion, and social function, paralleling the variables assessed in humans. A set of innovative experimental projects connect and integrate data from the human and animal parts, investigating the role of microRNA, neuroplasticity, immune signatures, (epi-)genetics and gene expression. Biomaterial from humans and animals are analyzed in parallel. The FOR2107 consortium will delineate pathophysiological entities with common neurobiological underpinnings ("biotypes") and pave the way for an etiologic understanding of the MP, potentially leading to their prevention, the prediction of individual disease courses, and novel therapies in the future.

Identifiants

pubmed: 30267149
doi: 10.1007/s00406-018-0943-x
pii: 10.1007/s00406-018-0943-x
doi:

Substances chimiques

Cacna1c protein, rat 0
Calcium Channels, L-Type 0
MicroRNAs 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

949-962

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : KI 588/14-1
Organisme : Deutsche Forschungsgemeinschaft
ID : KI 588/14-2
Organisme : Deutsche Forschungsgemeinschaft
ID : KI 588/17-1
Organisme : Deutsche Forschungsgemeinschaft
ID : KR 3822/7-1
Organisme : Deutsche Forschungsgemeinschaft
ID : KR 3822/7-2
Organisme : Deutsche Forschungsgemeinschaft
ID : NE 2254/1-2
Organisme : Deutsche Forschungsgemeinschaft
ID : DA 1151/5-1
Organisme : Deutsche Forschungsgemeinschaft
ID : DA 1151/5-2
Organisme : Deutsche Forschungsgemeinschaft
ID : SCHW 559/14-1
Organisme : Deutsche Forschungsgemeinschaft
ID : SCHW 559/14-2
Organisme : Deutsche Forschungsgemeinschaft
ID : WO 1732/4-1
Organisme : Deutsche Forschungsgemeinschaft
ID : WO 1732/4-2
Organisme : Deutsche Forschungsgemeinschaft
ID : AL 1145/5-2
Organisme : Deutsche Forschungsgemeinschaft
ID : CU 43/9-1
Organisme : Deutsche Forschungsgemeinschaft
ID : CU 43/9-2
Organisme : Deutsche Forschungsgemeinschaft
ID : GA 545/7-2
Organisme : Deutsche Forschungsgemeinschaft
ID : RI 908/11-2
Organisme : Deutsche Forschungsgemeinschaft
ID : WI 3439/3-2
Organisme : Deutsche Forschungsgemeinschaft
ID : NO 246/10-2
Organisme : Deutsche Forschungsgemeinschaft
ID : DE 1614/3-2
Organisme : Deutsche Forschungsgemeinschaft
ID : HA 7070/2-2
Organisme : Deutsche Forschungsgemeinschaft
ID : JA 1890/7-1
Organisme : Deutsche Forschungsgemeinschaft
ID : JA 1890/7-2
Organisme : Deutsche Forschungsgemeinschaft
ID : MU 1315/8-2
Organisme : Deutsche Forschungsgemeinschaft
ID : RE 737/20-2
Organisme : Deutsche Forschungsgemeinschaft
ID : PF 784/1-2

Références

EMBO J. 2009 Mar 18;28(6):697-710
pubmed: 19197241
Hum Brain Mapp. 2014 Apr;35(4):1190-200
pubmed: 23404764
J Psychiatr Res. 2012 Sep;46(9):1199-205
pubmed: 22687817
Biol Psychiatry. 2015 Aug 15;78(4):231-9
pubmed: 25636176
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18962-7
pubmed: 23112146
Biol Psychiatry. 2003 Apr 15;53(8):707-42
pubmed: 12706957
Front Behav Neurosci. 2015 May 01;9:102
pubmed: 25983681
Neuroimage. 2010 Jan 15;49(2):1831-6
pubmed: 19781653
Nature. 2009 May 28;459(7246):569-73
pubmed: 19404257
J Neuroimmune Pharmacol. 2013 Sep;8(4):900-20
pubmed: 23645137
Neuroimage. 2008 Oct 1;42(4):1569-76
pubmed: 18606232
Eur J Neurosci. 2011 Mar;33(6):1152-9
pubmed: 21395859
Neuroreport. 2001 Aug 28;12(12):2773-7
pubmed: 11522964
J Psychiatry Neurosci. 2013 Jul;38(4):249-58
pubmed: 23171695
Biol Mood Anxiety Disord. 2012 Feb 28;2:4
pubmed: 22738397
JAMA Psychiatry. 2015 Apr;72(4):305-15
pubmed: 25651064
PLoS One. 2010 Nov 29;5(11):e15497
pubmed: 21124738
Trends Cogn Sci. 2011 Sep;15(9):417-27
pubmed: 21839667
Nat Neurosci. 2005 Jun;8(6):828-34
pubmed: 15880108
Nat Genet. 2015 Nov;47(11):1236-41
pubmed: 26414676
Science. 2002 Jul 19;297(5580):400-3
pubmed: 12130784
Neuron. 2009 Sep 24;63(6):803-17
pubmed: 19778509
Hum Brain Mapp. 2009 Nov;30(11):3553-62
pubmed: 19347874
Mol Psychiatry. 2013 May;18(5):595-606
pubmed: 22525486
Biol Psychiatry. 2006 Jun 1;59(11):1006-20
pubmed: 16487491
J Neurosci. 2014 Aug 6;34(32):10616-23
pubmed: 25100595
JAMA Psychiatry. 2018 May 1;75(5):484-492
pubmed: 29590315
Schizophr Res. 2015 Jul;165(2-3):212-9
pubmed: 25935815
Schizophr Res. 2018 Jul;197:315-320
pubmed: 29409757
Nature. 2010 Aug 26;466(7310):1105-9
pubmed: 20622856
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):67-76
pubmed: 28624581
PLoS One. 2007 Dec 26;2(12):e1365
pubmed: 18159248
Curr Psychiatry Rep. 2011 Dec;13(6):467-75
pubmed: 21927805
JAMA Psychiatry. 2016 Jun 1;73(6):557-64
pubmed: 27145449
Neuroimage. 2018 May 15;172:450-460
pubmed: 29410079
Mol Cell Neurosci. 2010 Jan;43(1):146-56
pubmed: 19850129
Neuropsychopharmacology. 2015 Oct;40(11):2510-6
pubmed: 25801500
Nature. 2006 Jan 19;439(7074):283-9
pubmed: 16421561
Nat Neurosci. 2011 Sep 04;14(10):1240-2
pubmed: 21892155
Psychopharmacology (Berl). 2014 Jul;231(13):2567-77
pubmed: 24414610
Psychol Med. 2018 Oct;48(14):2391-2398
pubmed: 29415775
Biol Psychiatry. 2006 Apr 15;59(8):673-80
pubmed: 16458264
Nat Neurosci. 2015 May;18(5):666-73
pubmed: 25867122
Neuropsychopharmacology. 2011 Aug;36(9):1879-85
pubmed: 21525857
Aust N Z J Psychiatry. 2017 May;51(5):441-454
pubmed: 27539592
JAMA Psychiatry. 2014 Nov;71(11):1222-30
pubmed: 25188810
Neuron. 2010 Feb 11;65(3):373-84
pubmed: 20159450
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11650-5
pubmed: 21697510
Soc Cogn Affect Neurosci. 2018 Mar 1;13(3):341-348
pubmed: 29385621
Schizophr Bull. 2018 Jan 13;44(1):65-74
pubmed: 29036668
J Affect Disord. 2015 Sep 15;184:182-92
pubmed: 26093832
Cell Tissue Res. 2013 Oct;354(1):81-97
pubmed: 23576070
Lancet. 2013 Apr 20;381(9875):1371-1379
pubmed: 23453885
PLoS One. 2017 Feb 6;12(2):e0171595
pubmed: 28166306
Science. 2012 Oct 5;338(6103):75-9
pubmed: 23042886
Nat Med. 2012 Sep;18(9):1413-7
pubmed: 22885997
Hum Brain Mapp. 2013 Nov;34(11):2899-909
pubmed: 22696400
Curr Opin Psychiatry. 2011 Nov;24(6):519-25
pubmed: 21897249
Nat Neurosci. 2015 Oct;18(10):1386-93
pubmed: 26404713
Psychol Med. 2011 Jul;41(7):1551-61
pubmed: 21078228
Am J Med Genet B Neuropsychiatr Genet. 2012 Oct;159B(7):749-59
pubmed: 22887963
Transl Psychiatry. 2014 Dec 16;4:e490
pubmed: 25514753
Schizophr Bull. 2013 Jan;39(1):141-50
pubmed: 21799211
Biol Psychiatry. 2010 Jan 15;67(2):155-60
pubmed: 19748075
JAMA Psychiatry. 2015 Jan;72(1):68-74
pubmed: 25409415
Mol Cell Biol. 2012 Feb;32(3):619-32
pubmed: 22144581
Lancet. 2012 Mar 17;379(9820):1045-55
pubmed: 22189047
J Cell Biol. 2011 Sep 19;194(6):889-904
pubmed: 21930776
Nat Neurosci. 2010 Oct;13(10):1161-9
pubmed: 20877280
Eur Neuropsychopharmacol. 2017 Mar;27(3):261-273
pubmed: 28119084
Nat Rev Neurosci. 2006 Jul;7(7):583-90
pubmed: 16791147
Transl Psychiatry. 2015 Nov 10;5:e678
pubmed: 26556287
Nat Rev Neurosci. 2009 Dec;10(12):842-9
pubmed: 19888283
Neuroimage. 2014 Apr 1;89:256-61
pubmed: 24269271
Acta Psychiatr Scand. 2017 May;135(5):373-387
pubmed: 28122130

Auteurs

Tilo Kircher (T)

Department of Psychiatry and Psychotherapy, University of Marburg, Rudolf-Bultmann-Str. 8, 35039, Marburg, Germany. kircher2@staff.uni-marburg.de.
Centre for Mind, Brain and Behaviour, University of Marburg, Marburg, Germany. kircher2@staff.uni-marburg.de.

Markus Wöhr (M)

Centre for Mind, Brain and Behaviour, University of Marburg, Marburg, Germany.
Department of Experimental and Biological Psychology, University of Marburg, Marburg, Germany.

Igor Nenadic (I)

Department of Psychiatry and Psychotherapy, University of Marburg, Rudolf-Bultmann-Str. 8, 35039, Marburg, Germany.
Centre for Mind, Brain and Behaviour, University of Marburg, Marburg, Germany.

Rainer Schwarting (R)

Centre for Mind, Brain and Behaviour, University of Marburg, Marburg, Germany.
Department of Experimental and Biological Psychology, University of Marburg, Marburg, Germany.

Gerhard Schratt (G)

Department of Neuroscience, ETH Zürich, Zurich, Germany.

Judith Alferink (J)

Department of Psychiatry and Psychotherapy, University of Münster, Munich, Germany.

Carsten Culmsee (C)

Centre for Mind, Brain and Behaviour, University of Marburg, Marburg, Germany.
Institute for Pharmacology and Clinical Pharmacy, University of Marburg, Marburg, Germany.

Holger Garn (H)

Institute of Laboratory Medicine and Pathobiochemistry, University of Marburg, Marburg, Germany.

Tim Hahn (T)

Department of Psychiatry and Psychotherapy, University of Münster, Munich, Germany.

Bertram Müller-Myhsok (B)

Max Planck Institute of Psychiatry, Munich, Germany.

Astrid Dempfle (A)

Institute of Medical Informatics and Statistics, University of Kiel, Kiel, Germany.

Maik Hahmann (M)

Coordinating Centre for Clinical Trials, University of Marburg, Marburg, Germany.

Andreas Jansen (A)

Department of Psychiatry and Psychotherapy, University of Marburg, Rudolf-Bultmann-Str. 8, 35039, Marburg, Germany.
Centre for Mind, Brain and Behaviour, University of Marburg, Marburg, Germany.
Core-Facility Brainimaging, Faculty of Medicine, University of Marburg, Marburg, Germany.

Petra Pfefferle (P)

Comprehensive Biomaterial Bank Marburg, University of Marburg, Marburg, Germany.

Harald Renz (H)

Institute of Laboratory Medicine and Pathobiochemistry, University of Marburg, Marburg, Germany.

Marcella Rietschel (M)

Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.

Stephanie H Witt (SH)

Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.

Markus Nöthen (M)

Department of Genomics, Life and Brain Centre, University of Bonn, Bonn, Germany.

Axel Krug (A)

Department of Psychiatry and Psychotherapy, University of Marburg, Rudolf-Bultmann-Str. 8, 35039, Marburg, Germany.
Centre for Mind, Brain and Behaviour, University of Marburg, Marburg, Germany.

Udo Dannlowski (U)

Department of Psychiatry and Psychotherapy, University of Münster, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH